Detalhe da pesquisa
1.
Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative Review.
Infect Dis Ther
; 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38609668
2.
Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.
Open Forum Infect Dis
; 9(8): ofac304, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36046700
3.
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss.
PLoS Pathog
; 5(3): e1000345, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19300491
4.
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis.
AIDS
; 35(9): 1333-1342, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33730748
5.
Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes.
J Virol
; 83(19): 10245-9, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19605484
6.
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.
AIDS Res Hum Retroviruses
; 36(1): 13-18, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31507204
7.
Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere®) in patients with neovascular age-related macular degeneration.
Exp Ther Med
; 20(6): 162, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33093900
8.
Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review.
Antivir Ther
; 24(6): 393-404, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31503008
9.
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.
J Acquir Immune Defic Syndr
; 78(2): 125-135, 2018 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29474268
10.
Psychiatric Symptoms in Patients Receiving Dolutegravir.
J Acquir Immune Defic Syndr
; 74(4): 423-431, 2017 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27984559
11.
Salvage therapy with ritonavir-boosted amprenavir/fosamprenavir: virological and immunological response in two years follow-up.
HIV Clin Trials
; 6(2): 73-80, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15983891
12.
Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks.
Clin Drug Investig
; 35(3): 211-9, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25637061
13.
Venous and arterial blood lactate in HIV-infected patients.
Antivir Ther
; 7(4): 309-10, 2002 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-12553487
14.
Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.
Clin Vaccine Immunol
; 15(3): 562-8, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18184824
15.
Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy.
J Infect Dis
; 188(10): 1421-5, 2003 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-14624366
16.
Virologic and immunologic efficacy of the tenofovir/didanosine/lamivudine regimen.
J Acquir Immune Defic Syndr
; 42(3): 389-90, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-16763531